Avricore Health (AVCRF) Capital Expenditures (2016 - 2025)
Historic Capital Expenditures for Avricore Health (AVCRF) over the last 10 years, with Q3 2025 value amounting to -$11448.2.
- Avricore Health's Capital Expenditures rose 7682.61% to -$11448.2 in Q3 2025 from the same period last year, while for Sep 2025 it was $196157.8, marking a year-over-year decrease of 8247.19%. This contributed to the annual value of $132271.0 for FY2024, which is 8253.05% down from last year.
- Per Avricore Health's latest filing, its Capital Expenditures stood at -$11448.2 for Q3 2025, which was up 7682.61% from -$1275.3 recorded in Q2 2025.
- In the past 5 years, Avricore Health's Capital Expenditures registered a high of $1.4 million during Q4 2022, and its lowest value of -$465996.9 during Q3 2022.
- Its 5-year average for Capital Expenditures is $109992.6, with a median of -$30578.9 in 2021.
- Over the last 5 years, Avricore Health's Capital Expenditures had its largest YoY gain of 78945.47% in 2022, and its largest YoY loss of 92691.69% in 2022.
- Over the past 5 years, Avricore Health's Capital Expenditures (Quarter) stood at $162130.9 in 2021, then skyrocketed by 789.45% to $1.4 million in 2022, then fell by 13.42% to $1.2 million in 2023, then plummeted by 79.54% to $255446.5 in 2024, then crashed by 104.48% to -$11448.2 in 2025.
- Its Capital Expenditures stands at -$11448.2 for Q3 2025, versus -$1275.3 for Q2 2025 and -$46565.2 for Q1 2025.